In contrast to the depletion or inhibition of CDK12 in various cancer cell lines, the decreased expression of BRCA1/2 and some other HR factors was not found in ovarian and prostate CDK12-inactivated tumour samples (10,47,88,89). This evidence concerns the gene CDK12 and neoplasm.